MLN4924
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for MLN4924, covering 2013-07-16 to 2020-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors [Phase 1]